Search research articles
Contact Us
Filters
Showing results (11-20 of 53) with videos related to
Page
of 6
Sort By:
Expert Review of Clinical Immunology
|
September 15, 2016
Recent advances and future directions in understanding and treating Chlamydia-induced reactive arthritis
John D Carter, Alan P Hudson
Best Practice & Research. Clinical Rheumatology
|
November 22, 2011
Chlamydia-induced reactive arthritis: hidden in plain sight?
John D Carter, Robert D Inman
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
February 5, 2010
Atypical insufficiency fracture of the tibia associated with long-term bisphosphonate therapy
Michael D Breglia, John D Carter
Current Rheumatology Reports
|
August 11, 2007
Urticarial vasculitis
Natalie A Brown, John D Carter
Expert Opinion on Drug Safety
|
April 7, 2010
A safety assessment of tumor necrosis factor antagonists during pregnancy
Vanessa C Osting, John D Carter
Current Opinion in Rheumatology
|
May 7, 2010
The evolving story of Chlamydia-induced reactive arthritis
John D Carter, Alan P Hudson
The Journal of Rheumatology
|
October 7, 2004
Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison
John D Carter, Joanne Valeriano, Frank B Vasey
The Journal of Rheumatology
|
May 3, 2006
Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship
John D Carter, Joanne Valeriano, Frank B Vasey
International Journal of Dermatology
|
October 17, 2006
Hydroxychloroquine as a treatment for atrophoderma of Pasini and Pierini
John D Carter, Joanne Valeriano, Frank B Vasey
Clinical Rheumatology
|
December 22, 2016
Two cases demonstrating thalidomide's efficacy in refractory lupus nephritis
Rita Raturi, Avani A Patel, John D Carter
Page
of 6
Search research articles
Search
Showing results (11-20 of 53) with videos related to
Sort By:
Page
of 6
Expert Review of Clinical Immunology
|
September 15, 2016
Recent advances and future directions in understanding and treating Chlamydia-induced reactive arthritis
John D Carter, Alan P Hudson
Best Practice & Research. Clinical Rheumatology
|
November 22, 2011
Chlamydia-induced reactive arthritis: hidden in plain sight?
John D Carter, Robert D Inman
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
February 5, 2010
Atypical insufficiency fracture of the tibia associated with long-term bisphosphonate therapy
Michael D Breglia, John D Carter
Current Rheumatology Reports
|
August 11, 2007
Urticarial vasculitis
Natalie A Brown, John D Carter
Expert Opinion on Drug Safety
|
April 7, 2010
A safety assessment of tumor necrosis factor antagonists during pregnancy
Vanessa C Osting, John D Carter
Current Opinion in Rheumatology
|
May 7, 2010
The evolving story of Chlamydia-induced reactive arthritis
John D Carter, Alan P Hudson
The Journal of Rheumatology
|
October 7, 2004
Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison
John D Carter, Joanne Valeriano, Frank B Vasey
The Journal of Rheumatology
|
May 3, 2006
Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship
John D Carter, Joanne Valeriano, Frank B Vasey
International Journal of Dermatology
|
October 17, 2006
Hydroxychloroquine as a treatment for atrophoderma of Pasini and Pierini
John D Carter, Joanne Valeriano, Frank B Vasey
Clinical Rheumatology
|
December 22, 2016
Two cases demonstrating thalidomide's efficacy in refractory lupus nephritis
Rita Raturi, Avani A Patel, John D Carter
Page
of 6